Norwegian Health AS, as part of the Global Pharma Group AS, is pleased to announce a strategic distribution agreement with L&L Pharma GmbH, a growing distributor of pharmaceutical and nutraceutical products. This partnership marks a significant milestone in Norwegian Health AS’s international growth strategy, further strengthening its position as a key player in the health and wellness market.
Under the agreement, L&L Pharma GmbH will act as the distributor of Norwegian Health’s premium product portfolio in Germany and selected additional regions. The collaboration aligns with the company’s mission to bring high-quality, scientifically backed health products to consumers, expanding both reach and market influence.
“This agreement represents a tremendous opportunity for Norwegian Health AS and our shareholders,” said Thomas Storvestre, CEO of Global Pharma Group AS.
“Partnering with L&L Pharma GmbH allows us to expand our product offerings with innovative, high quality solutions that meet the growing demand for premium health and wellness products. We are confident that this partnership will drive sustainable growth and create long-term value for our investors.”
Rainer Ott, CEO of L&L Pharma GmbH, commented: “We are thrilled to collaborate with Norwegian Health AS to introduce innovative, science-backed nutritional supplements to German consumers. The ‘Made in Norway ’label serves as a key differentiator. With our expertise in product registration and distribution, we are committed to ensuring a successful market launch and long-term growth.”
The agreement is expected to deliver strong financial performance and strategic advantages for Norwegian Health AS. The first wave of products will be distributed via B2B channels (including pharmacies) and B2C starting from May 2025, with further expansion planned in the coming months. Norwegian Health AS remains committed to driving shareholder value through strategic partnerships, innovation, and market expansion. The company will continue to explore opportunities that reinforce its market leadership and growth trajectory.
